0
Article Tier 2 Detection Methods Environmental Sources Human Health Effects Policy & Risk Remediation Sign in to save

Meeting the Moment: Opportunities and Limitations for for Genetically Engineered Microbes for Bioremediation

AI summary Read the abstract

This review evaluated the potential and limitations of genetically engineered microbes for bioremediation of emerging contaminants including microplastics, PFAS, pharmaceuticals, and pesticides. The authors highlighted engineered Pseudomonas-Aspergillus combinations for PET/PE degradation and integrated membrane filtration as promising advances, while emphasizing need for regulatory frameworks for open-system GMO use.

As anthropogenic compounds are released into the environment at unprecedented rates, there is an ever-growing need for robust remediation strategies. Bioremediation, a method of immobilizing or transforming contaminants, is cost-competitive, environmentally friendly, and effective. With the global bioremediation market anticipated to grow by $8.29 billion between 2023 and 2028, this method of reducing pollutants represents a rapidly expanding sector of the bioeconomy. Millions of tons of pollutants now contaminate soil and groundwater, posing severe threats to human and environmental health. At the same time, as contaminants of emerging concern such as microplastics, pharmaceuticals, pesticides, and per- and polyfluorinated alkyl substances (PFAS) resist treatment with naturally occurring organisms, it may be useful to expand bioremediation’s toolkit to include genetically engineered microbes for bioremediation (GEMBs). There has been long-standing interest in developing GEMBs to enable faster remediation times and address a wider range of contaminants. Despite decades of investigation and development of GEMBs, none have been commercialized to date. Historically, the perceived need for GEMBs has not been sufficient to overcome the investment and risk in the context of an uncertain regulatory environment and a paucity of fundamental knowledge of GEMBs. However, as industries, environments, and human health experience disruptions from increasingly recalcitrant, widespread, and hazardous contaminants, the value proposition of GEMBs is more compelling than ever before. The contemporary challenges with managing environmental contamination coupled with advances in genetic engineering methods and renewed interest from researchers, developers, and policymakers signal an opportunity to realize the potential of GEMBs. To support safe and efficient development, characterization, and commercialization of GEMBs as a means of urgently addressing environmental contamination, we propose clarifying and restructuring the risk assessment process for GEMBs, establishing an interagency coordination office, collaboratively addressing critical knowledge gaps, and leveraging public-private partnerships.

More Papers Like This

Article Tier 2

From waste to opportunity: The potential of microbial biodegradation in plastic pollution mitigation

AI summary Read the abstract

This review explored microbial biodegradation as a strategy for managing plastic pollution, focusing on engineered Pseudomonas-Aspergillus consortia capable of co-metabolically degrading PET and PE. The authors proposed integrating membrane bioreactors with microbial degradation to achieve >90% plastic removal efficiency and outlined regulatory hurdles for open-system deployment.

Article Tier 2

Microbial degradation of contaminants of emerging concern: metabolic, genetic and omics insights for enhanced bioremediation

AI summary Read the abstract

This review covers how microorganisms have evolved the ability to break down emerging pollutants including plasticizers, pharmaceuticals, and pesticides, turning them into less harmful substances. Understanding the genes, enzymes, and metabolic pathways these microbes use could lead to cost-effective, eco-friendly cleanup methods for removing persistent contaminants -- including plastic-derived chemicals -- from the environment before they reach people.

Article

Genetically engineered microorganisms: A promising frontier for PFAS bioremediation

AI summary Read the abstract

This review examines the potential of genetically engineered microorganisms (GEMs) for breaking down persistent PFAS contaminants, highlighting how CRISPR-enhanced dehalogenases and metabolic pathway engineering offer a safer alternative to high-temperature incineration while presenting scalability and ecological containment challenges that require further research.

Article Tier 2

Microbial and multi-omics approaches for bioremediation of emerging contaminants: environmental impact and future engineering solutions

AI summary Read the abstract

This research review summarizes how scientists are using helpful microbes (bacteria, fungi, and algae) to clean up dangerous pollutants in our water and soil, including pharmaceuticals, pesticides, and microplastics that can harm human health. The study shows that these tiny organisms can naturally break down and remove many toxic chemicals from the environment. This matters because it could lead to cheaper, eco-friendly ways to clean up contaminated areas and protect our drinking water and food supply.

Article

Recent advances in microbial biotechnology for wastewater treatment

AI summary Read the abstract

This review surveys advances in microbial biotechnology for wastewater treatment, including engineered consortia, synthetic biology, CRISPR tools, and hybrid bioreactor systems, with specific attention to emerging contaminants such as microplastics, pharmaceuticals, and PFAS that conventional treatment systems inadequately address. These biotechnological innovations represent a promising frontier for removing microplastics at the treatment plant before they enter aquatic environments.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper